PUNE, India, July 6, 2017 /PRNewswire/ --
This report "Global TAVR Market: Industry Analysis & Outlook (2017-2021)" analyses the development of this market, with focus on the U.S, Asia Pacific and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report.
Complete report on transcatheter aortic valve replacement market (TAVR) spread across 78 pages, providing 4 company profiles with 48 charts is now available at http://www.marketreportsonline.com/576748.html.
Company Coverage of Transcatheter Aortic Valve Replacement Market: Edwards Lifesciences, Boston Scientific, Medtronic Plc. & St. Jude Medical, Inc.
The four major players: Edwards Lifesciences, Boston Scientific, Medtronic Plc. and St. Jude Medical, Inc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global TAVR market along with the study of the regional markets.
The global TAVR market is set to experience favourable growth driven by factors such as increasing elderly population, rising health care expenditure, increasing obese population and global economic development. Further, the scope of growth for this market will be broadened by increasing prevalence of aortic stenosis amongst the patients and rising demand for minimally invasive procedures. However, the growth of this budding market will be hindered by the business cycle fluctuations and risk of security breaches such as stringent regulations, high cost of TAVR devices and high risks associated with the TAVR procedure.
Purchase a copy of this "Global Transcatheter Aortic Valve Replacement Market" research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=576748.
Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a less intrusive method of replacing heart valve without undergoing the conventional by-pass surgery. Due to the less invasive nature of the surgery, it has emerged as the more feasible alternative to conventional surgical aortic valve replacement. Transcatheter aortic valve replacement is sometimes called as Transcatheter aortic valve implantation (TAVI). TAVR may be an option for people who are considered at intermediate or high risk of complications from surgical aortic valve replacement. It may also be suggested in certain cases where patient cannot undergo open-heart surgery. The decision to treat aortic stenosis with transcatheter aortic valve replacement is made after consultation with a multidisciplinary group of medical and surgical heart specialists who together determine the best treatment option for each individual.
Major Points from Table of Contents:
1.1 TAVR Overview
2. Global Market Analysis
2.1 Global TAVR Market by Value
2.2 Global TAVR Market Forecast by Value
2.3 Global TAVR Implant Volume
2.4 Global TAVR Implant Volume Forecast
2.5 Global TAVR Patient Population
2.6 Global TAVR Patient Population Forecast
3. Regional Market Analysis
3.1 The U.S.
3.2 Outside the U.S.
4. Market Dynamics
4.1 Growth Drivers
5.1 Global Market
5.2 The U.S.
5.3 Outside the U.S.
6. Company Profiles
Other Related Reports on Transcatheter Aortic Valve Replacement Market:
Global Transcatheter Aortic Valve Replacement (TAVR) Market Outlook to 2019: Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a less invasive method of replacing heart valve without undergoing the conventional by-pass surgery. Aortic valve replacement typically requires open heart surgery, thus it disqualifies patients who are at high risk for the process or are too weak to undergo a surgery. As a result, the market of heart valve surgical procedures is witnessing a continuous decline as more and more patients requiring valve replacement are at risk for a surgical treatment. Complete report available at http://www.marketreportsonline.com/444973.html.
The 2018-2023 World Outlook for Transcatheter Aortic Valve Replacement (TAVR) Devices: This study covers the world outlook for transcatheter aortic valve replacement (TAVR) devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. Complete report available at http://www.marketreportsonline.com/603662.html.
Explore more related reports on medical devices market at http://www.marketreportsonline.com/cat/medical-devices-market-research.html.
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001